213.45USD-1.05%Mkt Cap: 23.63B $P/E: 23.561d ago
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing,…
Industry Peers
Diagnostics & Researchvs Diagnostics & Research
P/E
Cheaper
P/B
Avg
Div Yield
Lower
1M Perf
Avg
$192.35BUSDP/E 28.4
$137.04BUSDP/E 37.5
$45.79BUSDP/E 44.2
$44.57BUSDP/E 41.5
$40.64BUSD
$37.20BUSDP/E 48.3
$36.91BUSDP/E 26.2
$34.38BUSDP/E 25.6
$29.40BUSDP/E 35.4
$26.44BUSDP/E 30.8
$23.32BUSDP/E 25.2
$22.39BUSD
$16.14BUSDP/E 35.6
$12.97BUSDP/E 27.0
$12.60BUSDP/E 54.3
$11.15BUSD
$9.03BUSDP/E 21.1
$6.22BUSD
$5.68BUSDP/E 228.5
$5.42BUSD
$5.09BUSDP/E 43.6
$4.63BUSDP/E 53.7
$3.60BUSDP/E 25.5
$3.39BUSD
$2.96BUSD
$2.05BUSD
$1.97BUSD
$1.52BUSDP/E 38.7
$1.55BUSDP/E 23.3
$1.50BUSD
$1.50BUSD
$1.13BUSD
$1.01BUSDP/E 21.1
$734.29MUSD
$623.59MUSDP/E 40.6
$607.49MUSD
$569.52MUSD
$297.91MUSDP/E 3.0
$290.61MUSD
$226.27MUSD
$182.12MUSD
$141.76MUSD
$106.30MUSD
$97.25MUSD
$94.30MUSDP/E 18.1
$79.32MUSD
$58.94MUSD
$45.15MUSD
$29.61MUSD
$27.97MUSD
$21.38MUSD
$17.72MUSD
$12.73MUSD
$12.18MUSD
$9.97MUSDP/E 62.6
$9.04MUSD
$9.20MUSD
$6.08MUSD
$5.34MUSD
$4.90MUSD
$5.08MUSD
$5.06MUSD
$3.86MUSDP/E 2.8
$3.69MUSD
$3.29MUSD
$3.29MUSD
$2.79MUSD
$1.01MUSD
$314.2KUSDP/E Infinity
$56.1KUSD
Indicators:|
Key Statistics
Company
Market Cap23.63B $
Enterprise Value29.86B $
Revenue (TTM)11.28B $
Gross Profit3.67B $
Net Income (TTM)992.00M $
Revenue/Share101.83 USD
Last Price213.45 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees57.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS74834L1008
Valuation
P/E (Trailing)23.56
P/E (Forward)18.16
PEG1.62
EV/EBITDA13.41
EV/Revenue2.65
P/S2.08
P/B3.19
EPS (TTM)9.05
EPS (Forward)11.67
52W Range
164.6592% of range217.41
52W High217.41 USD
52W Low164.65 USD
Profitability
Gross Margin33.21%
Oper. Margin14.20%
EBITDA Margin19.74%
Profit Margin8.99%
ROE13.84%
ROA6.11%
Growth
Revenue Growth9.20%
Earnings Growth15.50%
Cash Flow & Leverage
Operating CF1.89B $
CapEx (TTM)527.00M $
FCF Margin8.40%
FCF Yield4.01%
Net Debt6.01B $
Net Debt/EBITDA2.70
Balance Sheet
Debt/Equity0.92
Current Ratio1.18
Quick Ratio0.91
Book Value/Sh66.36 USD
Cash/Share3.550 USD
Dividends
Fwd Div Rate3.440 USD
Trail. Div Rate3.260 USD
Div. Yield1.62%
5Y Avg Yield1.85%
Payout Ratio36.02%
Ex-Div DateJul 8, 2026
Pay DateJul 22, 2026
Splits
Last Split2:1
Split DateJun 21, 2005
Analyst Consensus
Rating2.2 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)223.44 USD
Upside (mean)+4.7%
Target Range184.00 USD – 245.00 USD
$184.00+4.7% to mean$245.00
# Analysts16
Ownership
Shares Out.110.70M
Float110.09M
Insiders0.43%
Institutions97.93%
Short Interest
Short Ratio4.2d
Short % Float3.10%
Short % Out.3.09%
Shares Short3.42M
Short (prev mo.)3.72M
Technical
SMA 50196.13 (+8.8%)
SMA 200190.25 (+12.2%)
Beta0.59
S&P 52W Chg20.05%
Avg Vol (30d)584.55K
Avg Vol (10d)987.28K
Technical Indicators
RSI (14)66.2
MACD4.8258
MACD Signal3.4702
MACD Hist.+1.3556
BB Upper218.13 USD
BB Middle204.42 USD
BB Lower190.71 USD
BB Width13.41%
ATR (14)4.427 USD
Vol Ratio (20d)0.81x